Jennifer L Martin
Jennifer L Martin
Verifisert e-postadresse på griffith.edu.au
Sitert av
Sitert av
Thioredoxin—a fold for all reasons
JL Martin
Structure 3 (3), 245-250, 1995
Human sulfotransferases and their role in chemical metabolism
N Gamage, A Barnett, N Hempel, RG Duggleby, KF Windmill, JL Martin, ...
Toxicological Sciences 90 (1), 5-22, 2006
SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold
JL Martin, FM McMillan
Current opinion in structural biology 12 (6), 783-793, 2002
Functional group contributions to drug-receptor interactions
PR Andrews, DJ Craik, JL Martin
Journal of medicinal chemistry 27 (12), 1648-1657, 1984
Crystal structure of the DsbA protein required for disulphide bond formation in vivo
JL Martin, JCA Bardwell, J Kuriyan
Nature 365 (6445), 464-468, 1993
Protein disulfide isomerase: the structure of oxidative folding
CW Gruber, M Čemažar, B Heras, JL Martin, DJ Craik
Trends in biochemical sciences 31 (8), 455-464, 2006
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors
D Leung, K Schroder, H White, NX Fang, MJ Stoermer, G Abbenante, ...
Journal of Biological Chemistry 276 (49), 45762-45771, 2001
DSB proteins and bacterial pathogenicity
B Heras, SR Shouldice, M Totsika, MJ Scanlon, MA Schembri, JL Martin
Nature Reviews Microbiology 7 (3), 215-225, 2009
Post-crystallization treatments for improving diffraction quality of protein crystals
B Heras, JL Martin
Acta Crystallographica Section D: Biological Crystallography 61 (9), 1173-1180, 2005
Crystal structure of mammalian purple acid phosphatase
LW Guddat, AS McAlpine, D Hume, S Hamilton, J de Jersey, JL Martin
Structure 7 (7), 757-767, 1999
Crystal structures of reduced and oxidized DsbA: investigation of domain motion and thiolate stabilization
LW Guddat, JCA Bardwell, JL Martin
Structure 6 (6), 757-767, 1998
Targeting virulence not viability in the search for future antibacterials
B Heras, MJ Scanlon, JL Martin
British journal of clinical pharmacology 79 (2), 208-215, 2015
Structure of a Human Carcinogen-converting Enzyme, SULT1A1 structural and kinetic implications of substrate inhibition
NU Gamage, RG Duggleby, AC Barnett, M Tresillian, CF Latham, ...
Journal of Biological Chemistry 278 (9), 7655-7662, 2003
Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes
JL Martin, K Veluraja, K Ross, LN Johnson, GWJ Fleet, NG Ramsden, ...
Biochemistry 30 (42), 10101-10116, 1991
Structure of the Munc18c/Syntaxin4 N-peptide complex defines universal features of the N-peptide binding mode of Sec1/Munc18 proteins
SH Hu, CF Latham, CL Gee, DE James, JL Martin
Proceedings of the National Academy of Sciences 104 (21), 8773-8778, 2007
Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation
G Robin, K Chappell, MJ Stoermer, SH Hu, PR Young, DP Fairlie, ...
Journal of molecular biology 385 (5), 1568-1577, 2009
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
E Valkov, A Stamp, F DiMaio, D Baker, B Verstak, P Roversi, S Kellie, ...
Proceedings of the National Academy of Sciences 108 (36), 14879-14884, 2011
Crystal structure of human catecholamine sulfotransferase1
LM Bidwell, ME McManus, A Gaedigk, Y Kakuta, M Negishi, L Pedersen, ...
Journal of molecular biology 293 (3), 521-530, 1999
Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b
JL Martin, LN Johnson, SG Withers
Biochemistry 29 (48), 10745-10757, 1990
Ten Simple Rules to Achieve Conference Speaker Gender Balance
JL Martin
PLOS Computational Biology 10 (11), e1003903, 2014
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20